AnalystsCorinne JohnsonCorinne Johnson's Stock Forecasts
AnalystsCorinne Johnson
Sectors:
Analyst Ranking
Top 27%
#1478 out of 5510 analysts
Average Return
+21.88%
Win Rate
50%8 out of 16
Risk vs Reward
Poor
Good
Corinne Johnson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Amylyx Pharmaceuticals IncAMLX | +164.38% | $11.96 | $31.62 | 2025-09-16 - 2026-09-11 | Strong Buy |
Syndax Pharmaceuticals IncSNDX | +152.95% | $9.82 | $24.84 | 2025-07-10 - 2026-07-09 | Strong Buy |
Amylyx Pharmaceuticals IncAMLX | +148.71% | $7.39 | $18.38 | 2025-07-10 - 2026-07-09 | Strong Buy |
Arrivent Biopharma IncAVBP | +52.84% | $22.03 | $33.67 | 2025-07-10 - 2026-07-09 | Strong Buy |
Neurocrine Biosciences IncNBIX | +33.82% | $134.92 | $180.55 | 2025-07-10 - 2026-07-09 | Strong Buy |
Corinne Johnson Analyst Color
Get additional color on Corinne Johnson's coverage of popular stocks
Corinne Johnson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Neurocrine Biosciences IncNBIX | 2 | Strong Buy | $213.00 | +36.35% | Reinstates | 3 months ago |
Immunovant IncIMVT | 3 | Hold | $32.00 | -14.35% | Maintains | 5 months ago |
Syndax Pharmaceuticals IncSNDX | 3 | Strong Buy | $34.00 | +87.02% | Maintains | 5 months ago |
Tg Therapeutics IncTGTX | 1 | Hold | $39.00 | -27.63% | Maintains | 8 months ago |
Mbx Biosciences IncMBX | 1 | Strong Sell | $18.00 | -69.50% | Initiates Coverage On | 9 months ago |
Amylyx Pharmaceuticals IncAMLX | 2 | Strong Buy | $20.00 | -36.75% | Maintains | a year ago |
Avidity Biosciences IncRNAM | 2 | Strong Buy | $55.00 | N/A | Reinstates | a year ago |
Arrivent Biopharma IncAVBP | 3 | Strong Buy | $33.00 | N/A | Reinstates | a year ago |
Cg Oncology IncCGON | 3 | Strong Buy | $50.00 | N/A | Upgrades | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.